BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 22575407)

  • 41. Hypoglycemia during Short-Term Intensive Insulin Therapy and Its Association with Long-Term Glycemic Remission in Patients with Newly Diagnosed Type 2 Diabetes.
    Xu L; Zhang P; Huang Z; Zhong L; Li H; Liu L; Liu J; Xiao H; Li Y
    J Diabetes Res; 2020; 2020():4097469. PubMed ID: 32149152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of Hypoglycemia in the ASPIRE In-Home Study and Effects of Automatic Suspension of Insulin Delivery.
    Weiss R; Garg SK; Bergenstal RM; Klonoff DC; Bode BW; Bailey TS; Thrasher J; Schwartz F; Welsh JB; Kaufman FR;
    J Diabetes Sci Technol; 2015 May; 9(5):1016-20. PubMed ID: 25986629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycemic Variability and Insulin Needs in Patients with Type 1 Diabetes Mellitus Supplemented with Vitamin D: A Pilot Study Using Continuous Glucose Monitoring System.
    Felício KM; de Souza ACCB; Neto JFA; de Melo FTC; Carvalho CT; Arbage TP; de Rider Brito HA; Peixoto AS; de Oliveira AF; de Souza Resende F; Reis SS; Motta AR; da Costa Miranda H; Janau LC; Yamada ES; Felicio JS
    Curr Diabetes Rev; 2018; 14(4):395-403. PubMed ID: 28618984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey.
    Willis WD; Diago-Cabezudo JI; Madec-Hily A; Aslam A
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):123-30. PubMed ID: 23402452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypoglycemia observed during continuous glucose monitoring in patients with type 2 diabetes mellitus treated by subcutaneous insulin injection.
    Ito H; Abe M; Shinozaki M; Oshikiri K; Yamashita H; Nakashima M; Takaki A; Yukawa C; Furusho M; Antoku S; Mifune M; Togane M
    Diabetes Technol Ther; 2013 Jul; 15(7):586-90. PubMed ID: 23578166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improved glycemic control and lower frequency of severe hypoglycemia with insulin detemir; long-term experience in 105 children and adolescents with type 1 diabetes.
    Braun D; Konrad D; Lang-Muritano M; Schoenle E
    Pediatr Diabetes; 2008 Aug; 9(4 Pt 2):382-7. PubMed ID: 18331413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypoglycaemia and its management in primary care setting.
    Ibrahim M; Baker J; Cahn A; Eckel RH; El Sayed NA; Fischl AH; Gaede P; Leslie RD; Pieralice S; Tuccinardi D; Pozzilli P; Richelsen B; Roitman E; Standl E; Toledano Y; Tuomilehto J; Weber SL; Umpierrez GE
    Diabetes Metab Res Rev; 2020 Nov; 36(8):e3332. PubMed ID: 32343474
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of Personal Continuous Glucose Monitoring Device Is Associated With Reduced Risk of Hypoglycemia in a 16-Week Clinical Trial of People With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
    Jensen MH; Vestergaard P; Hirsch IB; Hejlesen O
    J Diabetes Sci Technol; 2022 Jan; 16(1):106-112. PubMed ID: 32945187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients.
    Ajjan RA; Abougila K; Bellary S; Collier A; Franke B; Jude EB; Rayman G; Robinson A; Singh BM
    Diab Vasc Dis Res; 2016 May; 13(3):211-9. PubMed ID: 27000105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hypoglycemia in diabetes mellitus].
    Irsigler K
    Acta Med Austriaca; 1992; 19(4):100-5. PubMed ID: 1290316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of glycemic variability on counterregulatory hormone responses to hypoglycemia in young children and adolescents with type 1 diabetes.
    Alghothani N; Dungan KM
    Diabetes Technol Ther; 2011 Nov; 13(11):1085-9. PubMed ID: 21770764
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline.
    McCall AL; Lieb DC; Gianchandani R; MacMaster H; Maynard GA; Murad MH; Seaquist E; Wolfsdorf JI; Wright RF; Wiercioch W
    J Clin Endocrinol Metab; 2023 Feb; 108(3):529-562. PubMed ID: 36477488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glucose variability indices predict the episodes of nocturnal hypoglycemia in elderly type 2 diabetic patients treated with insulin.
    Klimontov VV; Myakina NE
    Diabetes Metab Syndr; 2017; 11(2):119-124. PubMed ID: 27569727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Need to Change Regulatory Evaluation of Hypoglycemia in Trials of Diabetes Treatments.
    Klonoff DC; Fleming A; Gabbay R
    J Diabetes Sci Technol; 2020 Nov; 14(6):987-989. PubMed ID: 31744326
    [No Abstract]   [Full Text] [Related]  

  • 57. Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.
    Dailey G; Strange P
    Am J Manag Care; 2008 Jan; 14(1):25-30. PubMed ID: 18197742
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus.
    Meneghini LF; Traylor L; Schwartz SL
    Endocr Pract; 2010; 16(4):588-99. PubMed ID: 20350924
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative effectiveness of basal-bolus versus premix analog insulin on glycemic variability and patient-centered outcomes during insulin intensification in type 1 and type 2 diabetes: a randomized, controlled, crossover trial.
    Testa MA; Gill J; Su M; Turner RR; Blonde L; Simonson DC
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3504-14. PubMed ID: 22851487
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review.
    DeWitt DE; Hirsch IB
    JAMA; 2003 May; 289(17):2254-64. PubMed ID: 12734137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.